Archives
-
Lactate Workflows for Metabolic–Immune Research
2026-09-29
Use L-lactate as both a quantitative metabolic readout and a controlled perturbation in glycolysis, hypoxia, mitochondrial, and tumor–immune experiments. This workflow connects careful concentration control with the NAT1–ENO1–lactate mechanism reported in colorectal cancer research.
-
HABA Assays for Smarter PLGA Translation
2026-09-29
HABA can turn avidin–biotin surface chemistry into a practical translational readout for PLGA microspheres. This thought-leadership article connects HABA-based functional ligand analysis with particle transport, corticosteroid stability, and the quality-by-design decisions needed for intra-articular delivery.
-
Moxidectin: From Anthelmintic to Antifungal Probe
2026-09-28
Moxidectin is a macrocyclic lactone anthelmintic with an emerging role as a potentiator of polyene antifungals. This evidence-led guide explains its dual biology, the Candida ergosterol mechanism, and practical decisions for translational assay design.
-
Puromycin Aminonucleoside for Podocyte Injury Models
2026-09-28
Puromycin aminonucleoside offers a practical way to model podocyte damage, proteinuria, and glomerular pathology, with cell and animal workflows tailored to different research questions. This guide combines product-specific handling data with a cautious, assay-focused reading of a recent cancer study—without implying that its mechanism has been established in kidney disease.
-
From T-Cell Flexibility to Aconitase Redox Readouts
2026-09-27
CD8+ T-cell metabolic flexibility is shaped by post-transcriptional control, but transcript and splicing data do not reveal whether TCA-cycle enzyme function is preserved. This article connects the CD28–ARS2–PKM findings to a carefully bounded, practical use for aconitase activity measurement, with guidance on experimental design and interpretation.
-
Glycogen Colorimetric Assay Kit II in Circadian Studies
2026-09-26
The Glycogen Colorimetric Assay Kit II supports sensitive glycogen measurement in complex biological samples. This article explains how to interpret glycogen results when circadian training improves performance without changing measured glycogen stores.
-
Resazurin Cell Viability Assay Kit for Drug Studies
2026-09-25
Use resazurin to screen treatment responses without the wash and cell-lysis steps required by some endpoint assays. A practical workflow, grounded in a parthenolide study of lymphoid cancer cells, shows how to pair metabolic readouts with orthogonal tests so changes in signal are interpreted responsibly.
-
Puromycin Aminonucleoside for Podocyte Injury Models
2026-09-25
Build a practical podocyte injury workflow around Puromycin aminonucleoside, from dose-finding and stock preparation to proteinuria and glomerular readouts. The guide separates renal-model evidence from a pancreatic cancer reference study, translating its experimental rigor—not its disease mechanism—into assay choices.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-09-24
This 2025 review brings tumor hypoxia and immune-cell metabolism together to explain how oxygen and nutrient constraints can reinforce an immunosuppressive tumor microenvironment. Its central contribution is a connected framework for interpreting metabolic competition and immune dysfunction, while its therapeutic discussion highlights opportunities that still require validation in specific tumor and treatment contexts.
-
MTT Assays for Radiation-Activated Chemotherapy
2026-09-24
MTT can quantify changes in cellular reducing activity, but it cannot by itself prove that an X-ray-triggered drug reached its target. Learn how to interpret MTT data in radiation-activated chemotherapy experiments and choose controls that separate metabolic effects from cell loss.
-
Ko 143 for BCRP Efflux Assay Reliability
2026-09-23
Learn how Ko 143 (SKU A3533) can help distinguish BCRP-driven drug efflux from other causes of variable viability and cytotoxicity results. This scenario-based guide covers assay controls, solvent compatibility, data interpretation, and limits on translating cell and mouse findings.
-
Puromycin Aminonucleoside: A Mechanism-First Guide
2026-09-23
Puromycin aminonucleoside is a powerful chemical model of podocyte injury, proteinuria, and glomerular damage. This mechanism-first guide connects renal phenotyping with layered molecular assay design while clarifying what the compound can—and cannot—reveal about nephrotic disease.
-
Atorvastatin: From Mevalonate to Ferroptosis
2026-09-22
Explore how Atorvastatin, an HMG-CoA reductase inhibitor, connects mevalonate-pathway biology with ferroptosis-oriented hepatocellular carcinoma research. This evidence-led guide translates the latest transcriptomic and experimental findings into practical decisions for cardiovascular, vascular, and oncology assays.
-
BCA Protein Assay Kit for Lung Cell Research
2026-09-22
Convert limited-volume lung cell and tissue lysates into dependable protein concentration data for western blotting, ELISA, and enzyme assays. The BCA Protein Assay Kit combines a broad working range with 562 nm colorimetric detection, making it especially useful when consistent normalization is essential for hyperoxia and bronchopulmonary dysplasia studies.
-
Aconitase Activity in T-Cell Metabolic Flexibility
2026-09-21
CD28–ARS2-driven PKM alternative splicing provides a compelling model of metabolic flexibility in activated CD8+ T cells, but transcript and isoform changes do not fully reveal mitochondrial enzyme state. This thought-leadership article explains how an Aconitase Activity Colorimetric Assay Kit can add a functional, oxidative-stress-sensitive layer to translational immunometabolism studies while clarifying the assay’s scope and limitations.